Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06350539 · ClinicalTrials.gov registry record
Personalized Models for Cancer Research
A clinical trial of Solid Tumor, Adult, sponsored by New York Stem Cell Foundation Research Institute.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT06350539 is a study of Solid Tumor, Adult that is actively recruiting participants, run by New York Stem Cell Foundation Research Institute. The registered enrollment target is 500 participants, above the 184-participant average among 72 other Solid Tumor, Adult trials with a reported enrollment target (172% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06350539, a study of Solid Tumor, Adult, is actively recruiting participants, sponsored by New York Stem Cell Foundation Research Institute.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate cancer research ranging from disease mechanisms to personalized medicine approaches that will help to realize the promise of precision medicine for oncology.
Conditions Studied
Interventions
- OTHER Biological Sample Collection
Study Locations (1)
New York
- New York Stem Cell Foundation Research Institute - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2024-02-15 |
| Est. Completion | 2034-02-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06350539
The ClinicalTrials.gov registry entry for NCT06350539 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 184-participant average among 72 other Solid Tumor, Adult trials with a reported enrollment target (172% higher). The listed sponsor is New York Stem Cell Foundation Research Institute, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Solid Tumor, Adult appearing as the primary indexed condition, and to 1 intervention - of which Biological Sample Collection is the first listed.
NCT06350539 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06350539 about?
NCT06350539 is a clinical study titled "Personalized Models for Cancer Research". The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate cancer research ranging from disease mechanisms to personalized medicine approaches that will help to realize the promise of precision medicine for oncology.
What is the current status of trial NCT06350539?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2024-02-15. Estimated completion is 2034-02-15.
What conditions does trial NCT06350539 study?
This clinical trial studies the following conditions: Solid Tumor, Adult.
What interventions are being tested in trial NCT06350539?
The interventions under investigation include: Biological Sample Collection (OTHER).
Who is sponsoring clinical trial NCT06350539?
This trial is sponsored by New York Stem Cell Foundation Research Institute, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06350539 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Solid Tumor, Adult
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.
RECRUITING
-
Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors
RECRUITING · Phase 2
-
Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values
RECRUITING · NA
-
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
RECRUITING · Phase 1
-
Open-Label, Dose-Escalation With Expansion to Assess the Safety, Tolerability, and PK of TRE-515 in Subjects With Solid Tumors
RECRUITING · Phase 1
-
A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.